Global Human Microbiome Market

Dec 2018| VMR428A| Verified Market Research

Report Highlights

The global Human Microbiome Market was valued at USD 160.57 million in 2016 and is projected to reach USD 899.40million by 2025, growing at a CAGR of 21.10% from 2017 to 2025.

The human microbiota or microbiome is the aggregate of microorganisms that resides on or within any of a number of human tissues and biofluids, including the skin, mammary glands, placenta, seminal fluid etc.

Market Dynamics:
1. Market Drivers
1.1 Increased Focus on Human Microbiome Therapy
1.2 Human Microbiome as New Validated Target for Drug Development
1.3 Human Microbiome for Early Disease Detection and Diagnosis

2. Market Restraints
2.1 Lack of Expertise
2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease

Market Segmentation:
1. Global Human MicrobiomeMarket, by Product:
1.1 Instruments
1.1.1 Laboratory Instruments
1.1.2 Analyzers
1.2 Consumables
1.2.1 Kits
1.2.2 Reagents

2. Global Human MicrobiomeMarket, by Technology:
2.1 Cell Culture Technology
2.2 High-Throughput Technology
2.3 Omics Technology
2.4 Computational Tools

3. Global Human MicrobiomeMarket, by Disease:
3.1 Acute Diarrhea
3.2 Obesity
3.3 Diabetes
3.4 Autoimmune Disorders
3.5 Cancer
3.6 Mental Disorders
3.7 Other Diseases

4. Global Human Microbiome Market, by Application:
4.1 Therapeutics
4.2 Diagnostics

5. Global Human Microbiome Market, by Product type:
5.1 Probiotics
5.2 Foods
5.3 Prebiotics
5.4 Medical Foods
5.5 Diagnostic Devices
5.6 Drugs
5.7 Other Probiotic Supplements

6. Global Human Microbiome Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Enterome Bioscience
2. E.I. Du Pont De Nemours and Company
3. Merck & Co., Inc.
4. Metabiomics Corporation
5. Yakult Honsha Co., Ltd.
6. Microbiome Therapeutics, LLC
7. Osel, Inc.
8. Second Genome, Inc.
9. Vithera Pharmaceuticals
10. Vedanta Biosciences, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Research study on the Human MicrobiomeMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Verified Market Research
Price: $3950

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.